Gsk

French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.

GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21

French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.

France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.

French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.

Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.

Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.

GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.

Unilever's share of the total deal price is 3.3 billion euros ($3.75 billion), payable using cash, and shares in its subsidiary in India, Hindustan Unilever.

The GSK business is likely to fetch less than $4 billion, people close to the deal has told Reuters.

Last month, Kraft Heinz Co agreed to sell its popular health-drink brands Complan and Glucon-D, to Zydus Wellness Ltd for Rs 4,595 crore.

Using nothing more than a simple vial of saliva, millions of people have created DNA profiles on genealogy websites.

Completion of the buyout by GSK of Novartis 36.5% stake in the joint venture is currently expected to occur during the summer of 2018.

The deal is set to complete in the second quarter subject to the necessary approvals.

French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.

GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21

French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.

France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.

French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.

Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.

Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.

GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.

Unilever's share of the total deal price is 3.3 billion euros ($3.75 billion), payable using cash, and shares in its subsidiary in India, Hindustan Unilever.

The GSK business is likely to fetch less than $4 billion, people close to the deal has told Reuters.

Last month, Kraft Heinz Co agreed to sell its popular health-drink brands Complan and Glucon-D, to Zydus Wellness Ltd for Rs 4,595 crore.

Using nothing more than a simple vial of saliva, millions of people have created DNA profiles on genealogy websites.

Completion of the buyout by GSK of Novartis 36.5% stake in the joint venture is currently expected to occur during the summer of 2018.

The deal is set to complete in the second quarter subject to the necessary approvals.